» Articles » PMID: 37967168

Unraveling the Formation of Gelatin Nanospheres by Means of Desolvation

Overview
Journal Nano Lett
Specialty Biotechnology
Date 2023 Nov 15
PMID 37967168
Authors
Affiliations
Soon will be listed here.
Abstract

Gelatin nanoparticles (GNPs) have been widely studied for a plethora of biomedical applications, but their formation mechanism remains poorly understood, which precludes precise control over their physicochemical properties. This leads to time-consuming parameter adjustments without a fundamental grasp of the underlying mechanism. Here, we analyze and visualize in a time-resolved manner the mechanism by which GNPs are formed during desolvation of gelatin as a function of gelatin molecular weight and type of desolvating agent. Through various analytical and imaging techniques, we unveil a multistage process that is initiated by the formation of primary particles that are ∼18 nm in diameter (wet state). These primary particles subsequently assemble into colloidally stable GNPs with a raspberry-like structure and a hydrodynamic diameter of ∼300 nm. Our results create a basic understanding of the formation mechanism of gelatin nanoparticles, which opens new opportunities for precisely tuning their physicochemical and biofunctional properties.

Citing Articles

Protein-based nanoparticles for therapeutic nucleic acid delivery.

Eweje F, Walsh M, Ahmad K, Ibrahim V, Alrefai A, Chen J Biomaterials. 2024; 305:122464.

PMID: 38181574 PMC: 10872380. DOI: 10.1016/j.biomaterials.2023.122464.

References
1.
Geh K, Hubert M, Winter G . Optimisation of one-step desolvation and scale-up of gelatine nanoparticle production. J Microencapsul. 2016; 33(7):595-604. DOI: 10.1080/02652048.2016.1228706. View

2.
Stewart P . Cryo-electron microscopy and cryo-electron tomography of nanoparticles. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2016; 9(2). DOI: 10.1002/wnan.1417. View

3.
Nahar M, Mishra D, Dubey V, Jain N . Development, characterization, and toxicity evaluation of amphotericin B-loaded gelatin nanoparticles. Nanomedicine. 2008; 4(3):252-61. DOI: 10.1016/j.nano.2008.03.007. View

4.
Storp B, Engel A, Boeker A, Ploeger M, Langer K . Albumin nanoparticles with predictable size by desolvation procedure. J Microencapsul. 2012; 29(2):138-46. DOI: 10.3109/02652048.2011.635218. View

5.
Bello A, Kim D, Kim D, Park H, Lee S . Engineering and Functionalization of Gelatin Biomaterials: From Cell Culture to Medical Applications. Tissue Eng Part B Rev. 2020; 26(2):164-180. DOI: 10.1089/ten.TEB.2019.0256. View